Third Rock Ventures V, L.P.

Third Rock Ventures V, L.P. is listed in filings as 10% Owner at Rapport Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 28, 2026, including sale activity. Recent filings connect the profile to Rapport Therapeutics, Inc. Common Stock (RAPP). The current snapshot covers public activity from Apr 21, 2026 to May 28, 2026. Reported amounts are shown as $17.2M to $10.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.